These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24010503)

  • 1. Tachyphylaxis to topical glucocorticoids; what is the evidence?
    Taheri A; Cantrell J; Feldman SR
    Dermatol Online J; 2013 Jul; 19(7):18954. PubMed ID: 24010503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.
    Miller JJ; Roling D; Margolis D; Guzzo C
    J Am Acad Dermatol; 1999 Oct; 41(4):546-9. PubMed ID: 10495373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical therapies for the treatment of plaque psoriasis.
    Bagel J
    Cutis; 2009 Oct; 84(4 Suppl):3-13. PubMed ID: 19916297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of vitamin D analog use for the treatment of psoriasis.
    Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
    J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical factors determining the potency of topical corticosteroids.
    Kirkland R; Pearce DJ; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2006; 17(3):133-5. PubMed ID: 16854751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of topical therapy for psoriasis: results of a national survey.
    Liem WH; McCullough JL; Weinstein GD
    Cutis; 1995 May; 55(5):306-10. PubMed ID: 7614843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
    Zivkovich AH; Feldman SR
    J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the COBRA trial in current psoriasis practice.
    Koo JY
    Cutis; 2007 Nov; 80(5 Suppl):4-11. PubMed ID: 18154218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical therapies for psoriasis: evidence-based review.
    Afifi T; de Gannes G; Huang C; Zhou Y
    Can Fam Physician; 2005 Apr; 51(4):519-25. PubMed ID: 15856971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachyphylaxis to the action of topically applied corticosteroids.
    du Vivier A; Stoughton RB
    Arch Dermatol; 1975 May; 111(5):581-3. PubMed ID: 1130802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical steroids and corticophobia.
    Belloni Fortina A; Neri L
    G Ital Dermatol Venereol; 2013 Dec; 148(6):651-4. PubMed ID: 24442046
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial.
    Menter A
    Cutis; 2007 Nov; 80(5 Suppl):12-9. PubMed ID: 18154219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Coral reef' psoriasis: a marker of resistance to topical treatment.
    Feldman SR; Brown KL; Heald P
    J Dermatolog Treat; 2008; 19(5):257-8. PubMed ID: 18608734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
    Lebwohl M; Colón LE
    Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I topical corticosteroid use by psoriasis patients in an academic practice.
    Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. V. Vasoconstriction phaenomenon and tachyphylaxis after repeated steroid application (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):51-6. PubMed ID: 1259466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psoriasis bio-assay for topical corticosteroid activity.
    Dumas KJ; Scholtz JR
    Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.